tiprankstipranks
Advertisement
Advertisement

HK:1276 Stock Latest News

Hengrui Pharma Wins NMPA Nod for New Dalpiciclib Breast Cancer Indication
Company AnnouncementsHengrui Pharma Wins NMPA Nod for New Dalpiciclib Breast Cancer Indication
2d ago
1276
Hengrui Pharma Wins NMPA Approval for First Domestic New-Generation URAT1 Inhibitor
PremiumCompany Announcements
Hengrui Pharma Wins NMPA Approval for First Domestic New-Generation URAT1 Inhibitor
21d ago
1276
Hengrui Pharma seals global collaboration and licensing deal with Bristol-Myers Squibb
PremiumCompany Announcements
Hengrui Pharma seals global collaboration and licensing deal with Bristol-Myers Squibb
1M ago
1276
Hengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
PremiumCompany Announcements
Hengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
2M ago
1276
Hengrui Pharma Sets Nomination Committee to Tighten Board Governance
PremiumCompany Announcements
Hengrui Pharma Sets Nomination Committee to Tighten Board Governance
2M ago
1276
Hengrui Pharma Assumes KiOmed License from Hansoh in Connected Deal
PremiumCompany AnnouncementsHengrui Pharma Assumes KiOmed License from Hansoh in Connected Deal
2M ago
1276
Jiangsu Hengrui Sets Detailed Mandate for Board Audit Committee
Premium
Company Announcements
Jiangsu Hengrui Sets Detailed Mandate for Board Audit Committee
2M ago
1276
Hengrui Pharmaceuticals Posts Double-Digit Profit Growth in Strong Q1 2026
Premium
Company Announcements
Hengrui Pharmaceuticals Posts Double-Digit Profit Growth in Strong Q1 2026
2M ago
1276
Jiangsu Hengrui Sets 2025 Final Dividend and Tax Terms for H Shares
PremiumCompany Announcements
Jiangsu Hengrui Sets 2025 Final Dividend and Tax Terms for H Shares
2M ago
1276
Jiangsu Hengrui Sets 2025 Final Dividend and Record Date for H Shareholders
PremiumCompany Announcements
Jiangsu Hengrui Sets 2025 Final Dividend and Record Date for H Shareholders
2M ago
1276
Hengrui Pharma Shareholders Approve Dividends, Board Changes at 2025 AGM
PremiumCompany Announcements
Hengrui Pharma Shareholders Approve Dividends, Board Changes at 2025 AGM
2M ago
1276
Jiangsu Hengrui Outlines Board Composition and Key Governance Committees
PremiumCompany Announcements
Jiangsu Hengrui Outlines Board Composition and Key Governance Committees
2M ago
1276
Jiangsu Hengrui Schedules Board Meeting to Approve First-Quarter 2026 Results
PremiumCompany AnnouncementsJiangsu Hengrui Schedules Board Meeting to Approve First-Quarter 2026 Results
2M ago
1276
Jiangsu Hengrui Pharmaceuticals Publishes 2025 Audited Annual Results
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Publishes 2025 Audited Annual Results
3M ago
1276
Jiangsu Hengrui Pharmaceuticals Proposes Final 2025 Dividend
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Proposes Final 2025 Dividend
3M ago
1276
Hengrui Pharma Sets 2025 AGM to Approve Dividends and 20% Share Issuance Mandate
PremiumCompany Announcements
Hengrui Pharma Sets 2025 AGM to Approve Dividends and 20% Share Issuance Mandate
3M ago
1276
Jiangsu Hengrui Boosts Investment in Shanghai Regenelead via RMB750 Million Capital Increase
PremiumCompany Announcements
Jiangsu Hengrui Boosts Investment in Shanghai Regenelead via RMB750 Million Capital Increase
3M ago
1276
Hengrui Subsidiary Wins NMPA Nod for New Indication of Innovative HER2 Breast Cancer Drug
PremiumCompany Announcements
Hengrui Subsidiary Wins NMPA Nod for New Indication of Innovative HER2 Breast Cancer Drug
3M ago
1276
Hengrui Pharma Wins New China Approval for Hetrombopag Aplastic Anemia Use
PremiumCompany Announcements
Hengrui Pharma Wins New China Approval for Hetrombopag Aplastic Anemia Use
3M ago
1276
Jiangsu Hengrui sets March 2026 board meeting to approve 2025 results
PremiumCompany AnnouncementsJiangsu Hengrui sets March 2026 board meeting to approve 2025 results
3M ago
1276
Jiangsu Hengrui Sets Tenth Board Session with Director Changes and New INED
Premium
Company Announcements
Jiangsu Hengrui Sets Tenth Board Session with Director Changes and New INED
4M ago
1276
Jiangsu Hengrui Pharma Delays Board Re-election, Extends Current Directors’ Terms
Premium
Company Announcements
Jiangsu Hengrui Pharma Delays Board Re-election, Extends Current Directors’ Terms
5M ago
1276

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >